Cargando…
Information disclosure of COVID-19 specific medicine and stock price crash risk in China
This study investigates the impact of information disclosure of COVID-19 specific medicine on stock price crash risk. To achieve this goal, crawling massive announcements of listed companies in China and using OCR (optical character recognition) to abstract text, texture analysis is adopted to count...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013702/ https://www.ncbi.nlm.nih.gov/pubmed/35463295 http://dx.doi.org/10.1016/j.frl.2022.102890 |
_version_ | 1784688053139275776 |
---|---|
author | Duan, Jiangjiao Lin, Jingjing |
author_facet | Duan, Jiangjiao Lin, Jingjing |
author_sort | Duan, Jiangjiao |
collection | PubMed |
description | This study investigates the impact of information disclosure of COVID-19 specific medicine on stock price crash risk. To achieve this goal, crawling massive announcements of listed companies in China and using OCR (optical character recognition) to abstract text, texture analysis is adopted to count the keywords occurrence, which derives from a keywords list consisted of “specific medicine”, “vaccine” and others. Based on information disclosure of COVID-19 specific medicine, empirical tests are conducted. The results show that the abnormal COVID-19 disclosure intensifies the degree of stock price crash risk. It proves that information asymmetry exactly exists in listed company information disclosure process in the securities market. It also provides new evidence that exaggerated information disclosure caused stock prices crash. |
format | Online Article Text |
id | pubmed-9013702 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90137022022-04-18 Information disclosure of COVID-19 specific medicine and stock price crash risk in China Duan, Jiangjiao Lin, Jingjing Financ Res Lett Article This study investigates the impact of information disclosure of COVID-19 specific medicine on stock price crash risk. To achieve this goal, crawling massive announcements of listed companies in China and using OCR (optical character recognition) to abstract text, texture analysis is adopted to count the keywords occurrence, which derives from a keywords list consisted of “specific medicine”, “vaccine” and others. Based on information disclosure of COVID-19 specific medicine, empirical tests are conducted. The results show that the abnormal COVID-19 disclosure intensifies the degree of stock price crash risk. It proves that information asymmetry exactly exists in listed company information disclosure process in the securities market. It also provides new evidence that exaggerated information disclosure caused stock prices crash. Elsevier Inc. 2022-08 2022-04-18 /pmc/articles/PMC9013702/ /pubmed/35463295 http://dx.doi.org/10.1016/j.frl.2022.102890 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Duan, Jiangjiao Lin, Jingjing Information disclosure of COVID-19 specific medicine and stock price crash risk in China |
title | Information disclosure of COVID-19 specific medicine and stock price crash risk in China |
title_full | Information disclosure of COVID-19 specific medicine and stock price crash risk in China |
title_fullStr | Information disclosure of COVID-19 specific medicine and stock price crash risk in China |
title_full_unstemmed | Information disclosure of COVID-19 specific medicine and stock price crash risk in China |
title_short | Information disclosure of COVID-19 specific medicine and stock price crash risk in China |
title_sort | information disclosure of covid-19 specific medicine and stock price crash risk in china |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013702/ https://www.ncbi.nlm.nih.gov/pubmed/35463295 http://dx.doi.org/10.1016/j.frl.2022.102890 |
work_keys_str_mv | AT duanjiangjiao informationdisclosureofcovid19specificmedicineandstockpricecrashriskinchina AT linjingjing informationdisclosureofcovid19specificmedicineandstockpricecrashriskinchina |